Download in electronic PDF format for $25



Search the Complete Journal Archives

Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations

Author(s):  Bryson Evan,Hartman Rachel,Arnold John,Gorman Greg,Sweitzer Sarah.Asbill Scott

Issue:  Mar/Apr 2015 - Volume 19, Number 2
View All Articles in Issue

Abstract:  Cyclobenzaprine has been commonly compounded by pharmacists into topically applied dosage forms for the treatment of pain disorders. However, the efficacy and transdermal penetration of topically applied compounded cyclobenzaprine is currently unknown. In this study, the transdermal penetration of cyclobenzaprine was studied in Franz diffusion cells using porcine skin. Cyclobenzaprine was compounded in two commercially available bases; Lipobase, Lipoderm, and a standard poloxamer lecithin organogel. In addition, cyclobenzaprine was tested in an in vivo formalin pain model. Cyclobenzaprine 5% compounded into all three bases yielded significant transdermal penetration and results in modest levels of cyclobenzaprine being retained in the skin tissue. Systemically administered cyclobenzaprine (10 mcg/kg), but not topically administered cyclobenzaprine (1% and 5%), attenuated nociception in a rodent formalin pain model.

Related Keywords: Evan Bryson, Rachel Hartman, BSc, John Arnold, PhD, Greg Gorman, PhD, Sarah Sweitzer, PhD, Scott Asbill, PhD, cyclobenzaprine, chronic pain, topical preparation, transdermal delivery, skin permeation, transdermal penetration, vehicle, commercial bases, formalin pain model, pain-related behavior, antinociception, pain control, analgesia, topical analgesics, muscle relaxant, permeability studies

Related Categories: EXCIPIENTS, PAIN MANAGEMENT, PEER-REVIEWED, DOSAGE FORMS/DRUG CARRIERS, NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations Bryson Evan, Hartman Rachel, Arnold John, Gorman Greg, Sweitzer Sarah.Asbill Scott Mar/Apr 2015 161-166 Buy
Veterinary Transdermal Medications: A to Z Davidson Gigi S Mar/Apr 2003 106 Buy
Skin Penetration and Antinociception of Topical Gabapentin Formulations Bryson Evan, Asbill Scott, Sweitzer Sarah Nov/Dec 2014 504-511 Buy
Analgesic Efficacy and Transdermal Penetration of Topical Gabapentin Creams: Finding an Optimal Dose and Pre-treatment Time Heustess Allie, Spigener Shuler, Sweitzer Sarah, Romero-Sandoval Alfonso, Asbill Scott Mar/Apr 2015 167-173 Buy
In Vitro Skin Penetration and Skin Content of Progesterone from Various Topical Formulations Heustess Allie, Asbill Scott, Eagerton David, Arnold John Nov/Dec 2014 512-515 Buy
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso Jul/Aug 2014 278-286 Buy
Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott May/Jun 2013 247-253 Buy
The Release and Transdermal Penetration of Baclofen Formulated in a Poloxamer Lecithin Organogel Arnold John J, Asbill Scott Nov/Dec 2009 569-571 Buy
Transdermal Delivery of Nisoldipine: Refinement of Vehicles El Maghraby Gamal M, Ahmed Amal A, Osman Mohamed A Mar/Apr 2015 152-160 Buy
Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives Trimble John, Light Bob May/Jun 2016 250-256 Buy